These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29631635)

  • 1. Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models.
    Abd-Elrahman KS; Hamilton A; Vasefi M; Ferguson SSG
    Mol Brain; 2018 Apr; 11(1):19. PubMed ID: 29631635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
    Hamilton A; Vasefi M; Vander Tuin C; McQuaid RJ; Anisman H; Ferguson SS
    Cell Rep; 2016 May; 15(9):1859-65. PubMed ID: 27210751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optineurin deletion disrupts metabotropic glutamate receptor 5-mediated regulation of ERK1/2, GSK3β/ZBTB16, mTOR/ULK1 signaling in autophagy.
    Ibrahim KS; McLaren CJ; Abd-Elrahman KS; Ferguson SSG
    Biochem Pharmacol; 2021 Mar; 185():114427. PubMed ID: 33513340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease.
    Hamilton A; Esseltine JL; DeVries RA; Cregan SP; Ferguson SS
    Mol Brain; 2014 May; 7():40. PubMed ID: 24886239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent.
    Abd-Elrahman KS; Hamilton A; Albaker A; Ferguson SSG
    ACS Pharmacol Transl Sci; 2020 Apr; 3(2):334-344. PubMed ID: 32296772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.
    Abd-Elrahman KS; Albaker A; de Souza JM; Ribeiro FM; Schlossmacher MG; Tiberi M; Hamilton A; Ferguson SSG
    Sci Signal; 2020 Dec; 13(662):. PubMed ID: 33323410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mGluR5 antagonism increases autophagy and prevents disease progression in the
    Abd-Elrahman KS; Hamilton A; Hutchinson SR; Liu F; Russell RC; Ferguson SSG
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice.
    Abd-Elrahman KS; Ferguson SSG
    Mol Brain; 2019 Apr; 12(1):35. PubMed ID: 30961637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.
    Haas LT; Salazar SV; Smith LM; Zhao HR; Cox TO; Herber CS; Degnan AP; Balakrishnan A; Macor JE; Albright CF; Strittmatter SM
    Cell Rep; 2017 Jul; 20(1):76-88. PubMed ID: 28683325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    Chen Y; Zhang Y; Chen Q; Liu Y; Wei X; Wu M; Zhang K; Liu Y; Wei W
    J Alzheimers Dis; 2023; 91(3):1197-1214. PubMed ID: 36565127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease.
    de Souza JM; Abd-Elrahman KS; Ribeiro FM; Ferguson SSG
    Mol Brain; 2020 Aug; 13(1):118. PubMed ID: 32859226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease.
    Bellozi PMQ; Gomes GF; da Silva MCM; Lima IVA; Batista CRÁ; Carneiro Junior WO; Dória JG; Vieira ÉLM; Vieira RP; de Freitas RP; Ferreira CN; Candelario-Jalil E; Wyss-Coray T; Ribeiro FM; de Oliveira ACP
    Neuropharmacology; 2019 Dec; 160():107785. PubMed ID: 31541651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.
    Cimino PJ; Yang Y; Li X; Hemingway JF; Cherne MK; Khademi SB; Fukui Y; Montine KS; Montine TJ; Keene CD
    Exp Mol Pathol; 2013 Apr; 94(2):366-71. PubMed ID: 23318649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model.
    Panagaki T; Gengler S; Hölscher C
    J Alzheimers Dis; 2018; 66(1):195-218. PubMed ID: 30282365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
    Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
    Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q.
    Spurrier J; Nicholson L; Fang XT; Stoner AJ; Toyonaga T; Holden D; Siegert TR; Laird W; Allnutt MA; Chiasseu M; Brody AH; Takahashi H; Nies SH; Pérez-Cañamás A; Sadasivam P; Lee S; Li S; Zhang L; Huang YH; Carson RE; Cai Z; Strittmatter SM
    Sci Transl Med; 2022 Jun; 14(647):eabi8593. PubMed ID: 35648810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.